Heng‐Ying Pu

1.2k total citations · 1 hit paper
10 papers, 491 citations indexed

About

Heng‐Ying Pu is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Heng‐Ying Pu has authored 10 papers receiving a total of 491 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Cancer Research and 1 paper in Surgery. Recurrent topics in Heng‐Ying Pu's work include RNA modifications and cancer (6 papers), Cancer-related molecular mechanisms research (5 papers) and MicroRNA in disease regulation (2 papers). Heng‐Ying Pu is often cited by papers focused on RNA modifications and cancer (6 papers), Cancer-related molecular mechanisms research (5 papers) and MicroRNA in disease regulation (2 papers). Heng‐Ying Pu collaborates with scholars based in China and United States. Heng‐Ying Pu's co-authors include Rui‐Hua Xu, Qi‐Nian Wu, Zexian Liu, Huai‐Qiang Ju, Peishan Hu, Miao‐Zhen Qiu, Jin‐Fei Lin, Kai Yu, Junzhong Lin and Qi Meng and has published in prestigious journals such as Cancer Research, Oncogene and Clinical Cancer Research.

In The Last Decade

Heng‐Ying Pu

10 papers receiving 485 citations

Hit Papers

Phosphorylated NFS1 weakens oxaliplatin-based chemosensit... 2022 2026 2023 2024 2022 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Heng‐Ying Pu China 9 378 201 110 80 70 10 491
Reid Loveless United States 11 332 0.9× 137 0.7× 94 0.9× 127 1.6× 85 1.2× 14 507
Di Yang China 9 333 0.9× 121 0.6× 94 0.9× 73 0.9× 72 1.0× 21 435
Wuping Yang China 11 268 0.7× 159 0.8× 109 1.0× 37 0.5× 68 1.0× 26 422
Qi-Tao Chen China 7 404 1.1× 226 1.1× 50 0.5× 139 1.7× 63 0.9× 9 582
Huaixin Xing China 12 437 1.2× 326 1.6× 73 0.7× 56 0.7× 80 1.1× 20 656
George Baltatzis Greece 11 268 0.7× 134 0.7× 71 0.6× 60 0.8× 69 1.0× 23 444
Zheng Jin China 11 217 0.6× 105 0.5× 99 0.9× 137 1.7× 68 1.0× 31 442
Zhicheng Gong China 12 350 0.9× 136 0.7× 66 0.6× 33 0.4× 96 1.4× 26 490
Peijie Zheng China 8 268 0.7× 166 0.8× 176 1.6× 41 0.5× 70 1.0× 14 492
Yunhao Wu China 10 327 0.9× 226 1.1× 52 0.5× 55 0.7× 97 1.4× 14 436

Countries citing papers authored by Heng‐Ying Pu

Since Specialization
Citations

This map shows the geographic impact of Heng‐Ying Pu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heng‐Ying Pu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heng‐Ying Pu more than expected).

Fields of papers citing papers by Heng‐Ying Pu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heng‐Ying Pu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heng‐Ying Pu. The network helps show where Heng‐Ying Pu may publish in the future.

Co-authorship network of co-authors of Heng‐Ying Pu

This figure shows the co-authorship network connecting the top 25 collaborators of Heng‐Ying Pu. A scholar is included among the top collaborators of Heng‐Ying Pu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heng‐Ying Pu. Heng‐Ying Pu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Luo, Xiaojing, Yun‐Xin Lu, Yun Wang, et al.. (2024). M6A-modified lncRNA FAM83H-AS1 promotes colorectal cancer progression through PTBP1. Cancer Letters. 598. 217085–217085. 14 indexed citations
2.
Liu, Jia, Xiaojing Luo, Yan‐Xing Chen, et al.. (2023). Long noncoding RNA Regulating ImMune Escape regulates mixed lineage leukaemia protein‐1‐H3K4me3‐mediated immune escape in oesophageal squamous cell carcinoma. Clinical and Translational Medicine. 13(9). e1410–e1410. 30 indexed citations
3.
Liu, Zexian, Zhao-Lei Zeng, Xiao-Jing Luo, et al.. (2022). The Macrophage-Associated LncRNA MALR Facilitates ILF3 Liquid–Liquid Phase Separation to Promote HIF1α Signaling in Esophageal Cancer. Cancer Research. 83(9). 1476–1489. 37 indexed citations
4.
Lin, Jin‐Fei, Peishan Hu, Yiyu Wang, et al.. (2022). Phosphorylated NFS1 weakens oxaliplatin-based chemosensitivity of colorectal cancer by preventing PANoptosis. Signal Transduction and Targeted Therapy. 7(1). 54–54. 226 indexed citations breakdown →
5.
Wang, Yingnan, Dan‐Yun Ruan, Zixian Wang, et al.. (2022). Targeting the cholesterol-RORα/γ axis inhibits colorectal cancer progression through degrading c-myc. Oncogene. 41(49). 5266–5278. 6 indexed citations
6.
Wu, Qi‐Nian, Xiao-Jing Luo, Jia Liu, et al.. (2021). MYC-Activated LncRNA MNX1-AS1 Promotes the Progression of Colorectal Cancer by Stabilizing YB1. Cancer Research. 81(10). 2636–2650. 59 indexed citations
7.
Hu, Peishan, Ting Li, Jin‐Fei Lin, et al.. (2020). VDR–SOX2 signaling promotes colorectal cancer stemness and malignancy in an acidic microenvironment. Signal Transduction and Targeted Therapy. 5(1). 183–183. 46 indexed citations
8.
Luo, Hui, Zhe Yang, Wei Wei, et al.. (2018). Enzymatically synthesized poly(amino-co-ester) polyplexes for systemic delivery of pcDNA-miRNA-214 to suppress colorectal cancer liver metastasis. Journal of Materials Chemistry B. 6(40). 6365–6376. 8 indexed citations
9.
Pu, Heng‐Ying, Rui Xu, Mei‐Yin Zhang, et al.. (2017). Identification of microRNA-615-3p as a novel tumor suppressor in non-small cell lung cancer. Oncology Letters. 13(4). 2403–2410. 25 indexed citations
10.
Wei, Rongrong, Lan Cao, Heng‐Ying Pu, et al.. (2015). TERTPolymorphism rs2736100-C Is Associated with EGFR Mutation–Positive Non–Small Cell Lung Cancer. Clinical Cancer Research. 21(22). 5173–5180. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026